4/A: INNOSPEC CFO Amends Stock Sale Prices

INNOSPEC's EVP & CFO, Ian Cleminson, filed an amended Form 4 to correct previously reported stock sale prices from February 27, 2026.

Summary

• Ian Cleminson, Executive Vice President & Chief Financial Officer of INNOSPEC INC., filed a Form 4/A to amend a previous Form 4 filed on March 3, 2026.
• The amendment corrects the transaction prices for two sales of Common Stock that occurred on February 27, 2026.
• The first transaction involved the sale of 1,149 shares at a corrected weighted average price of $76.3 per share, with prices ranging from $75.5001 to $76.55.
• The second transaction involved the sale of 1,231 shares at a corrected weighted average price of $76.79 per share, with prices ranging from $76.555 to $77.0713.
• Following these transactions, Ian Cleminson beneficially owns 20,357 shares of Common Stock.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is an administrative correction to previously reported insider trading data and does not indicate any new operational or financial developments for INNOSPEC INC.

Positives

• The stock sales were conducted pursuant to a Rule 10b5-1(c) plan, indicating pre-arranged, non-discretionary transactions, which is generally viewed as a positive for corporate governance and transparency in insider trading.

Future Outlook

NA

Management Comments

• The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that Form 4/A filings are routine for correcting minor discrepancies in insider trading reports and do not typically reflect broader industry trends or competitive shifts. The use of a 10b5-1 plan for insider sales is a standard practice to manage potential conflicts of interest.

Stakeholder Impact

• Shareholders: Provides corrected transparency regarding executive stock sales, reinforcing compliance with reporting requirements.

Next Steps

• The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer, or a security holder.

Key Dates

Recommendation

This Form 4/A is an administrative correction of previously reported insider stock sales by the EVP & CFO. The sales were conducted under a Rule 10b5-1 plan, indicating pre-scheduled transactions rather than a reaction to new company developments. As such, the filing itself does not provide new material information to warrant a change in investment stance, hence a 'hold' recommendation.

Keywords

INNOSPEC INC., IOSP, Form 4/A, Insider Trading, Stock Sale, Executive Compensation, Ian Cleminson, SEC Filing, Corporate Governance, Rule 10b5-1